Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -1.57% |
|
-3.46% | -18.90% |
Jun. 11 | 22NW Fund Submits Shareholder Proposals to Lifecore Biomedical | CI |
May. 20 | 22NW Fund Nominates Candidates to the Board of Lifecore Biomedical | CI |
Financials (USD)
Sales 2024 * | 126M | Sales 2025 * | 145M | Capitalization | 153M |
---|---|---|---|---|---|
Net income 2024 * | 6M | Net income 2025 * | 18M | EV / Sales 2024 * | 1.22 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.05 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
8.66
x | Employees | 459 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.63% |
Latest transcript on Lifecore Biomedical, Inc.
1 day | -1.57% | ||
1 week | -3.46% | ||
Current month | -14.04% | ||
1 month | -15.77% | ||
3 months | -0.40% | ||
6 months | -17.02% | ||
Current year | -18.90% |
![Extreme 4.8](/images/extremecours_fleche.png)
![Extreme 4.8](/images/extremecours_fleche.png)
![Extreme 4.5](/images/extremecours_fleche.png)
![Extreme 4.5](/images/extremecours_fleche.png)
![Extreme 1.52](/images/extremecours_fleche.png)
![Extreme 1.52](/images/extremecours_fleche.png)
![Extreme 1.52](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
John Morberg
DFI | Director of Finance/CFO | 60 | 21-01-17 |
Steve Laninga
COO | Chief Operating Officer | - | 19-12-31 |
Matt Augustson
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nelson Obus
BRD | Director/Board Member | 77 | 18-10-11 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 20-10-13 |
Katrina Houde
BRD | Director/Board Member | 66 | 19-08-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +10.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 5.02 | -1.57% | 599,059 |
24-06-20 | 5.1 | +4.29% | 236,848 |
24-06-18 | 4.89 | -5.05% | 149,930 |
24-06-17 | 5.15 | -0.96% | 193,992 |
24-06-14 | 5.2 | -1.33% | 160,722 |
Delayed Quote Nasdaq, June 21, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.90% | 153M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- LFCR Stock